Expert Interview
A Second Perspective: Discussing the potential of Axsome's AXS-05 (dextromethorphan-bupropion) for smoking cessation
Ticker(s): AXSM-
Private Practice for 27 Years
-
manage at least 200 patients a week with a smoking addiction
-
somewhat familiar with the ongoing development of AXS-05 (dextromethorphan-bupropion)
by Axsome Therapeutics
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
